1.
Clin Infect Dis
; 73(9): e3120-e3123, 2021 11 02.
Article
in English
| MEDLINE | ID: covidwho-1501040
ABSTRACT
We compared severe acute respiratory syndrome coronavirus 2 seroprevalence estimated from commercial laboratory residual sera and a community household survey in metropolitan Atlanta during April and May 2020 and found these 2 estimates to be similar (4.94% vs 3.18%). Compared with more representative surveys, commercial sera can provide an approximate measure of seroprevalence.